Tocagen inc (TOCA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
License revenue

36

18,036

41

49

-

License revenue

-

-

-

-

51

Operating expenses:
Research and development

45,299

51,080

29,113

27,218

19,172

General and administrative

16,248

12,809

8,556

4,521

3,833

Total operating expenses

61,547

63,889

37,669

31,739

23,005

Loss from operations

-61,511

-45,853

-37,628

-31,690

-22,954

Other income (expense), net:
Interest income

1,564

1,534

595

215

126

Interest expense

3,820

2,930

1,932

2,052

339

Loss on disposal of assets

-1,187

-7

-

-

-

Gain on lease modification

1,439

-

-

-

-

Change in fair value of preferred stock warrants

-

-

-37

-50

-111

Loss before income taxes

-63,515

-47,256

-38,928

-33,477

-

Income tax expense

1

1,699

1

1

-

Total other expense, net

-

-

-

-

-102

Net loss

-63,516

-48,955

-38,929

-33,478

-23,056

Other comprehensive income (loss):
Net unrealized (loss) gain on investments

33

11

-34

58

-52

Comprehensive loss

-63,483

-48,944

-38,963

-33,420

-23,108

Net loss per common share, basic and diluted

-2.69

-2.44

-2.66

-15.22

-10.57

Weighted-average number of common shares outstanding, basic and diluted

23,630

20,059

14,607

2,199

2,182